Capstone (CAPS) vs GRI Bio (GRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Capstone is the larger company by market cap ($3.7 million vs $3.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAPS | GRI |
|---|---|---|
| Share price | $0.1409 | $1.68 |
| Market cap | $3.72M | $3.67M |
| 1-day change | +0.57% | -9.19% |
| EPS (TTM) | $-3.32 | $-14.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.36 | $64.12 |
| 52-week low | $0.13 | $1.36 |
| Distance from 52-week high | -89.64% | -97.38% |
| Analyst consensus | none | none |
| Avg. price target upside | +2029.17% | +1001.19% |
| Average volume | 4.35M | 328.06K |
| Shares outstanding | 26.38M | 2.19M |
| Employees | 93 | 3 |
| Sector | Basic Materials | Healthcare |
| Industry | Building Materials | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Capstone in Basic Materials and GRI Bio in Healthcare.
About Capstone
CAPS stock →Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.
Basic Materials · Building Materials · 93 employees
About GRI Bio
GRI stock →GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis.
Healthcare · Biotechnology · 3 employees
CAPS vs GRI FAQ
Which is bigger, Capstone or GRI Bio?
Capstone (CAPS) is larger, with a market capitalization of $3.72M compared with $3.67M for GRI Bio (GRI).
Are Capstone and GRI Bio in the same industry?
No. Capstone is in the Basic Materials sector, while GRI Bio is in Healthcare.